Apellis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03753U1060
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityAPLS / Apellis Pharmaceuticals, Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Jane Street Group, Llc ownership in APLS / Apellis Pharmaceuticals, Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 0 shares of Apellis Pharmaceuticals, Inc. (US:APLS) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 50,114 shares of Apellis Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (APLS) in the form of stock options. The firm currently holds call options representing 210,900 of underlying shares valued at $8,484,507 USD and put options representing 161,500 of underlying shares valued at $6,497,145 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

APLS / Apellis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -50,114 -100.00 0 -100.00
2026-02-12 2025-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 50,114 -243,085 -82.91 1,259 -81.04 0.0002
2025-11-14 2025-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 293,199 47,000 19.09 6,635 55.71 0.0010
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 246,199 -9,893 -3.86 4,262 -23.91 0.0008
2025-05-19 2025-03-31 13F/A-1 APELLIS PHARMACEUTICALS COM 03753U106 256,092 160,107 166.80 5,601 82.89 0.0014
2025-05-14 2025-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 256,092 160,107 5,601 0.0012
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 95,985 76,705 397.85 3,063 450.72 0.0007
2024-11-15 2024-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 19,280 -181,609 -90.40 556 -92.78 0.0001
2024-08-15 2024-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 200,889 71,880 55.72 7,706 1.62 0.0018
2024-05-16 2024-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 129,009 -305,692 -70.32 7,583 -70.86 0.0016
2024-02-15 2023-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 434,701 161,475 59.10 26,021 150.37 0.0068
2023-11-15 2023-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 273,226 -207,856 -43.21 10,394 -76.29 0.0034
2023-08-14 2023-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 481,082 417,698 659.00 43,827 948.47 0.0147
2023-05-16 2023-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 63,384 49,363 352.06 4,181 476.55 0.0017
2023-02-15 2022-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 14,021 -2,977 -17.51 725 -37.55 0.0003
2022-11-15 2022-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 16,998 -77,584 -82.03 1,161 -72.85 0.0005
2022-08-16 2022-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 94,582 19,472 25.92 4,277 12.05 0.0018
2022-05-17 2022-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 75,110 -25,601 -25.42 3,817 -19.83 0.0012
2022-02-15 2021-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 100,711 84,768 531.69 4,761 806.86 0.0016
2021-11-16 2021-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 15,943 -18,619 -53.87 525 -75.96 0.0002
2021-08-16 2021-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 34,562 11,464 49.63 2,184 120.38 0.0009
2021-05-18 2021-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 23,098 -33,854 -59.44 991 -69.58 0.0005
2021-02-17 2020-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 56,952 14,382 33.78 3,258 153.74 0.0016
2020-11-17 2020-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 42,570 19,591 85.26 1,284 71.20 0.0008
2020-08-17 2020-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 22,979 22,979 -46.02 750 -41.59 0.0006
2020-05-15 2020-03-31 13F APELLIS PHARMACEUTICALS COM 03753U106 0 -8,135 -100.00 0 -100.00
2020-02-14 2019-12-31 13F APELLIS PHARMACEUTICALS COM 03753U106 8,135 -87,589 -91.50 249 -89.20 0.0003
2019-11-14 2019-09-30 13F APELLIS PHARMACEUTICALS COM 03753U106 95,724 82,285 612.29 2,306 576.25 0.0038
2019-08-15 2019-06-30 13F APELLIS PHARMACEUTICALS COM 03753U106 13,439 13,439 341 0.0006
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F APELLIS PHARMACEUTICALS COM Call 210,900 -19.81 8,485 28.43 n/a n/a n/a
2026-02-12 2025-12-31 13F APELLIS PHARMACEUTICALS COM Call 263,000 -12.77 6,607 -3.17 n/a n/a n/a
2025-11-14 2025-09-30 13F APELLIS PHARMACEUTICALS COM Call 301,500 46.72 6,823 91.79 n/a n/a n/a
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM Call 205,500 110.99 3,557 67.00 n/a n/a n/a
2025-05-19 2025-03-31 13F/A APELLIS PHARMACEUTICALS COM Call 97,400 -50.61 2,130 -66.15 n/a n/a n/a
2025-05-14 2025-03-31 13F APELLIS PHARMACEUTICALS COM Call 97,400 2,130 n/a n/a n/a
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM Call 197,200 -59.00 6,293 -54.64 n/a n/a n/a
2024-11-15 2024-09-30 13F APELLIS PHARMACEUTICALS COM Call 481,000 5.48 13,872 -20.70 n/a n/a n/a
2024-08-15 2024-06-30 13F APELLIS PHARMACEUTICALS COM Call 456,000 51.34 17,492 -1.23 n/a n/a n/a
2024-05-16 2024-03-31 13F APELLIS PHARMACEUTICALS COM Call 301,300 -70.72 17,710 -71.25 n/a n/a n/a
2024-02-15 2023-12-31 13F APELLIS PHARMACEUTICALS COM Call 1,029,000 17.00 61,596 84.11 n/a n/a n/a
2023-11-15 2023-09-30 13F APELLIS PHARMACEUTICALS COM Call 879,500 381.39 33,456 101.02 n/a n/a n/a
2023-08-14 2023-06-30 13F APELLIS PHARMACEUTICALS COM Call 182,700 -29.51 16,644 -2.65 n/a n/a n/a
2023-05-16 2023-03-31 13F APELLIS PHARMACEUTICALS COM Call 259,200 -21.14 17,097 0.58 n/a n/a n/a
2023-02-15 2022-12-31 13F APELLIS PHARMACEUTICALS COM Call 328,700 -7.30 16,997 -29.82 n/a n/a n/a
2022-11-15 2022-09-30 13F APELLIS PHARMACEUTICALS COM Call 354,600 138.79 24,219 260.67 n/a n/a n/a
2022-08-16 2022-06-30 13F APELLIS PHARMACEUTICALS COM Call 148,500 19.37 6,715 6.23 n/a n/a n/a
2022-05-17 2022-03-31 13F APELLIS PHARMACEUTICALS COM Call 124,400 219.79 6,321 243.72 n/a n/a n/a
2022-02-15 2021-12-31 13F APELLIS PHARMACEUTICALS COM Call 38,900 -85.46 1,839 -79.15 n/a n/a n/a
2021-11-16 2021-09-30 13F APELLIS PHARMACEUTICALS COM Call 267,600 194.07 8,820 53.36 n/a n/a n/a
2021-08-16 2021-06-30 13F APELLIS PHARMACEUTICALS COM Call 91,000 47.25 5,751 116.86 n/a n/a n/a
2021-05-18 2021-03-31 13F APELLIS PHARMACEUTICALS COM Call 61,800 32.62 2,652 -0.53 n/a n/a n/a
2021-02-17 2020-12-31 13F APELLIS PHARMACEUTICALS COM Call 46,600 -24.60 2,666 0.53 n/a n/a n/a
2020-11-17 2020-09-30 13F APELLIS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-17 2020-06-30 13F APELLIS PHARMACEUTICALS COM Call 34,200 1,117 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F APELLIS PHARMACEUTICALS COM Put 161,500 -40.73 6,497 -5.08 n/a n/a n/a
2026-02-12 2025-12-31 13F APELLIS PHARMACEUTICALS COM Put 272,500 30.70 6,845 45.08 n/a n/a n/a
2025-11-14 2025-09-30 13F APELLIS PHARMACEUTICALS COM Put 208,500 -3.29 4,718 26.42 n/a n/a n/a
2025-08-14 2025-06-30 13F APELLIS PHARMACEUTICALS COM Put 215,600 -34.49 3,732 -48.15 n/a n/a n/a
2025-05-19 2025-03-31 13F/A APELLIS PHARMACEUTICALS COM Put 329,100 7.90 7,197 -26.05 n/a n/a n/a
2025-05-14 2025-03-31 13F APELLIS PHARMACEUTICALS COM Put 329,100 7,197 n/a n/a n/a
2025-02-14 2024-12-31 13F APELLIS PHARMACEUTICALS COM Put 305,000 11.56 9,733 23.44 n/a n/a n/a
2024-11-15 2024-09-30 13F APELLIS PHARMACEUTICALS COM Put 273,400 -25.42 7,885 -43.93 n/a n/a n/a
2024-08-15 2024-06-30 13F APELLIS PHARMACEUTICALS COM Put 366,600 223.00 14,063 110.79 n/a n/a n/a
2024-05-16 2024-03-31 13F APELLIS PHARMACEUTICALS COM Put 113,500 -47.41 6,672 -48.35 n/a n/a n/a
2024-02-15 2023-12-31 13F APELLIS PHARMACEUTICALS COM Put 215,800 -24.68 12,918 18.53 n/a n/a n/a
2023-11-15 2023-09-30 13F APELLIS PHARMACEUTICALS COM Put 286,500 78.39 10,898 -25.51 n/a n/a n/a
2023-08-14 2023-06-30 13F APELLIS PHARMACEUTICALS COM Put 160,600 7.71 14,631 48.77 n/a n/a n/a
2023-05-16 2023-03-31 13F APELLIS PHARMACEUTICALS COM Put 149,100 146.45 9,835 214.39 n/a n/a n/a
2023-02-15 2022-12-31 13F APELLIS PHARMACEUTICALS COM Put 60,500 -49.88 3,128 -62.06 n/a n/a n/a
2022-11-15 2022-09-30 13F APELLIS PHARMACEUTICALS COM Put 120,700 -7.15 8,244 40.23 n/a n/a n/a
2022-08-16 2022-06-30 13F APELLIS PHARMACEUTICALS COM Put 130,000 -8.84 5,879 -18.87 n/a n/a n/a
2022-05-17 2022-03-31 13F APELLIS PHARMACEUTICALS COM Put 142,600 292.84 7,246 322.26 n/a n/a n/a
2022-02-15 2021-12-31 13F APELLIS PHARMACEUTICALS COM Put 36,300 -95.65 1,716 -93.76 n/a n/a n/a
2021-11-16 2021-09-30 13F APELLIS PHARMACEUTICALS COM Put 834,300 1,239.17 27,499 598.48 n/a n/a n/a
2021-08-16 2021-06-30 13F APELLIS PHARMACEUTICALS COM Put 62,300 3,937 n/a n/a n/a
2021-05-17 2021-03-31 13F APELLIS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-17 2020-12-31 13F APELLIS PHARMACEUTICALS COM Put 11,700 -50.84 669 -6.82 n/a n/a n/a
2020-11-17 2020-09-30 13F APELLIS PHARMACEUTICALS COM Put 23,800 37.57 718 27.08 n/a n/a n/a
2020-08-17 2020-06-30 13F APELLIS PHARMACEUTICALS COM Put 17,300 565 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.